“…In recent years, functional magnetic resonance imaging (fMRI), either based on the blood oxygenation level-dependent (BOLD) contrast, arterial spin labelling, or a mixture of both, has demonstrated its effectiveness as a method to assess CVR. As a result, its use is spreading into clinical practice, where its potential as a diagnostic measure is being ascertained in different diseases, spanning from vascular diseases (Hartkamp, Bokkers, van Osch, de Borst, & Hendrikse, 2017;Markus & Cullinane, 2001;Webster et al, 1995;Ziyeh et al, 2005), to stroke and aphasia (Krainik, Hund-Georgiadis, Zysset, & Von Cramon, 2005;Van Oers et al, 2018), brain tumors (Fierstra et al, 2018;Zacà, Jovicich, Nadar, Voyvodic, & Pillai, 2014), neurodegenerative diseases (Camargo et al, 2015;Glodzik, Randall, Rusinek, & de Leon, 2013;Marshall et al, 2014), hypertension (Iadecola & Davisson, 2008;Leoni et al, 2011;Tchistiakova, Anderson, Greenwood, & Macintosh, 2014), lifestyle habits (Friedman et al, 2008;Gonzales et al, 2014), sleep apnea (Buterbaugh et al, 2015;Prilipko, Huynh, Thomason, Kushida, & Guilleminault, 2014), and traumatic brain injury or concussions (Churchill, Hutchison, Graham, & Schweizer, 2020;Markus & Cullinane, 2001).…”